SCHEMBL6309705

SCHEMBL6309705

NS(=O)(=O)c1ccc(-c2oc(CC(=O)NO)nc2-c2ccc(F)c(Cl)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 8/20 0.46
PTGS2 P35354 8/20 0.46
SOS1 Q07889 2/20 0.45
CA2 P00918 4/20 0.44
CA12 O43570 3/20 0.43
CA1 P00915 3/20 0.43
CA9 Q16790 3/20 0.43
RXRA P19793 2/20 0.42
RXRB P28702 2/20 0.42
RXRG P48443 2/20 0.42
EPHX2 P34913 1/20 0.41
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
NR4A1 P22736 1/20 0.38
NR4A2 P43354 1/20 0.38
NR4A3 Q92570 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6316495 0.90 PTGS1 (0.51) PTGS1PTGS2SOS1CA2CA12
SCHEMBL8604016 0.87 CA2 (0.44) PTGS1PTGS2SOS1CA2CA12
SCHEMBL6310934 0.87 RXRA (0.49) PTGS1PTGS2CA2CA12CA1
SCHEMBL6308845 0.87 RXRA (0.49) PTGS1PTGS2CA2CA12CA1
SCHEMBL5733857 0.86 NR4A2 (0.50) PTGS1PTGS2SOS1CA2CA12
SCHEMBL6315576 0.85 PTGS2 (0.50) PTGS1PTGS2CA2CA12CA9
SCHEMBL6309178 0.85 NR4A2 (0.44) PTGS1PTGS2SOS1CA2CA12
SCHEMBL6308685 0.85 PTGS2 (0.60) PTGS1PTGS2CA2CA12CA1
SCHEMBL6309710 0.85 NR4A2 (0.44) PTGS1PTGS2RXRARXRBRXRG
SCHEMBL6314997 0.83 PTGS2 (0.52) PTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6875785-B2 Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors PHARMACIA CORPORATION (US) 2005-04-05 US claimed